Literature DB >> 8146304

In vitro radiation-induced neoplastic progression of low-grade uroepithelial tumors.

S Pazzaglia1, X R Chen, C B Aamodt, S Q Wu, C Kao, K W Gilchrist, R Oyasu, C A Reznikoff, M A Ritter.   

Abstract

Recent interest has focused on the identification of molecular genetic mechanisms in multistep neoplastic transformation. In vitro exposure of simian virus 40 (SV40)-immortalized human uroepithelial cells (SV-HUC) that are environmentally relevant to bladder carcinogens has been shown to produce tumorigenic transformation, as assessed by the ability of cells exposed to a carcinogen to form xenograph tumors with heterogeneous cancer phenotypes ranging from very aggressive, invasive high-grade carcinomas to superficial low-grade indolent tumors. In addition, exposure of a low-grade indolent tumor generated in the SV-HUC system, MC-T11, to the same carcinogens results in neoplastic progression as assessed by the production of high-grade aggressive cancers. In the present study, we show neoplastic progression of MC-T11 after in vitro exposure to a single dose of 6 Gy X rays. In addition, we show that the chromosome deletions, including losses of 4q, 11p, 13q and 18, observed in these radiation-induced tumors are similar to those observed in carcinogen-induced tumors, thus supporting the hypothesis that the experimental cell system, not the transforming agent, dictates the genetic losses required for tumorigenic transformation and progression.

Entities:  

Mesh:

Year:  1994        PMID: 8146304

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

1.  Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.

Authors:  David S Yee; Shahrokh F Shariat; William T Lowrance; Joseph R Sterbis; Kinjal C Vora; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni; Jaspreet S Sandhu
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

2.  Secondary malignancies following radiotherapy for prostate cancer.

Authors:  Petros Sountoulides; Nikolaos Koletsas; Dimitris Kikidakis; Konstantinos Paschalidis; Nikolaos Sofikitis
Journal:  Ther Adv Urol       Date:  2010-06

3.  Immortalisation of human urothelial cells.

Authors:  J L Petzoldt; I M Leigh; P G Duffy; C Sexton; J R Masters
Journal:  Urol Res       Date:  1995

Review 4.  Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer.

Authors:  A Lopez-Beltran; R J Luque; R Mazzucchelli; M Scarpelli; R Montironi
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

5.  Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy.

Authors:  Masaki Shiota; Akira Yokomizo; Ario Takeuchi; Kenjiro Imada; Keijiro Kiyoshima; Junichi Inokuchi; Katsunori Tatsugami; Saiji Ohga; Katsumasa Nakamura; Hiroshi Honda; Seiji Naito
Journal:  Oncotarget       Date:  2015-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.